SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010288
Filing Date
2019-11-07
Accepted
2019-11-07 08:12:53
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20190930x10q.htm 10-Q 1821200
2 EX-10.1 sbbp-20190930ex101bc2b98.htm EX-10.1 79936
3 EX-31.1 sbbp-20190930ex31112b144.htm EX-31.1 18343
4 EX-32.1 sbbp-20190930ex32188092c.htm EX-32.1 11472
  Complete submission text file 0001558370-19-010288.txt   6106362

Data Files

Seq Description Document Type Size
5 EX-101.INS sbbp-20190930.xml EX-101.INS 1212968
6 EX-101.SCH sbbp-20190930.xsd EX-101.SCH 42222
7 EX-101.CAL sbbp-20190930_cal.xml EX-101.CAL 48732
8 EX-101.DEF sbbp-20190930_def.xml EX-101.DEF 134217
9 EX-101.LAB sbbp-20190930_lab.xml EX-101.LAB 409651
10 EX-101.PRE sbbp-20190930_pre.xml EX-101.PRE 290332
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 191198216
SIC: 2834 Pharmaceutical Preparations